{"id": "1375007637029412865", "creation": 1616662341.0, "user_id": "15754217", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Safety and #immunogenicity of a #recombinant tandem-repeat dimeric #RBD-based protein #subunit #vaccine (#ZF2001) against #COVID19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials https://t.co/0oZiC3ze9b", "first_save": 1634559108.199414, "hashtags": ["#SAFETY", "#IMMUNOGENICITY", "#RECOMBINANT", "#RBD", "#SUBUNIT", "#VACCINE", "#ZF2001", "#COVID19"]}